# China Stroke Primary Prevention Trial

> **NCT00794885** · PHASE4 · COMPLETED · sponsor: **Shenzhen Ausa Pharmed Co.,Ltd** · enrollment: 20702 (actual)

## Conditions studied

- Primary Hypertension

## Interventions

- **DRUG:** Enalapril/folic acid
- **DRUG:** Enalapril maleate

## Key facts

- **NCT ID:** NCT00794885
- **Lead sponsor:** Shenzhen Ausa Pharmed Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2013-08
- **Final completion:** 2014-06
- **Target enrollment:** 20702 (ACTUAL)
- **Last updated:** 2014-08-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00794885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00794885, "China Stroke Primary Prevention Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00794885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*